Trials / Completed
CompletedNCT04158466
A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens
A Study to Evaluate the Safety and Efficacy of a Kalifilcon A Contact Lens for Daily Disposable Use
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 252 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate the safety and efficacy of a new silicone hydrogel daily disposable contact lens, kalifilcon A compared to the Bausch + Lomb Biotrue ONE day® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.
Detailed description
Approximately 247 participants (494 eyes) will be enrolled in at approximately 20 investigative sites in the United States (US). A minimum of 20% of the randomized participants will be of Japanese descent (for example, both maternal and paternal grandparents born in Japan).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Kalifilcon A Daily Disposable Contact Lenses | Contact lens |
| DEVICE | Biotrue ONEday Daily Disposable Contact Lenses | Contact lens |
Timeline
- Start date
- 2019-05-31
- Primary completion
- 2019-11-12
- Completion
- 2019-11-12
- First posted
- 2019-11-08
- Last updated
- 2020-11-19
- Results posted
- 2020-11-19
Locations
16 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04158466. Inclusion in this directory is not an endorsement.